Johnson & Johnson’s Janssen unit has filed for approval of its multiple myeloma CAR-T ciltacabtagene autoleucel in Europe, chasing after a rival therapy from Bristol-Myers Squibb. The BCMA-targeting ...
In an interview with The Drive, Chief Program Engineer at Ford, Greg Goodall described how the team behind the 2025 Ford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback